Human Trials
-
{
- All
- News
- Videos
-
Breakthrough: Universal Coronavirus Vaccine Designed By AI Passes Human Trial
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans. Here is how this needle-free super-antigen aims to future-proof humanity against all future mutations.
-
Nipah Breakthrough: Japan To Begin First Human Vaccine Trial In April
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
-
Nipah Breakthrough: Japan To Begin First Human Vaccine Trial In April
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
-
Elon Musk's Startup Implants First Human Brain Chip. Here's How It Works
Elon Musk on Tuesday announced that his company Neuralink has implanted the first brain chip in a human patient. The initial results are "promising", the billionaire said, adding that the product is named Telepathy.
-
Playboy Model Aims To Be First With Elon Musk's Neuralink Chip: "I Could Climb Everest At 90"
Kayla Kayden, the 35-year-old adult film star, said she expects the chip to improve her brain power.
-
World's First Trial With Voluntary Covid Exposure Found Safe In Young Adults: Study
The world's first human challenge trial in which volunteers were deliberately exposed to COVID-19 to advance research into the disease was found to be safe in healthy young adults, one of the companies running the study said on Wednesday.
-
US COVID-19 Vaccine Hopeful Of Using Gates Foundation Cash To Prepare For Human Trial
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.
-
Covaxin Crosses Half-Way Mark In Phase-3 Trials, Says Bharat Biotech
India's first and only phase III trial of a COVID-19 vaccine has crossed 13,000 subjects - the half-way mark - and proceeding successfully across multiple sites in India, Bharat Biotech, the maker of the inoculant Covaxin, announced today. The trials in the first and second phases had led to promising results.
-
UAE To Host Second Human Trial Abroad Of Russia's COVID-19 Vaccine Sputnik V
Human trials of Russia's COVID-19 vaccine, named Sputnik V, will be held in the United Arab Emirates, the second country after Belarus to take part in the programme of which results are expected before the end of November, Moscow said on Monday.
-
Covishield Vaccine: Phase II Human Trial Of Oxford COVID-19 Vaccine Candidate Begins In Pune
The Phase II human clinical trial of the Oxford COVID-19 vaccine candidate, being manufactured by the Pune-based Serum Institute of India (SII), began at a medical college and hospital in the city today.
-
India Readies 5 Sites For Final Phase Of Human Trials Of Oxford COVID Vaccine
Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology (DBT) Renu Swarup said on Monday.
-
Man Receives First Dose Of Covaxin In Phase-I Of Human Trial At Delhi AIIMS
The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at Delhi AIIMS on Friday and the first dose of the injection was administered to a man who is in his 30s.
-
Oxford COVID-19 Vaccine Shows Promise In Early Testing: Study
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.
-
Human Clinical Trials For COVID Vaccine Initiated In India: Top Medical Body ICMR
Human clinical trials for a vaccine for COVID-19 has been initiated in the country with approximately 1,000 volunteers participating in the exercise for each of the two indigenously developed vaccine candidates, the ICMR said on Tuesday.
-
NewLink Says Ebola Vaccine Trial Could Start in Weeks
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
-
Breakthrough: Universal Coronavirus Vaccine Designed By AI Passes Human Trial
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans. Here is how this needle-free super-antigen aims to future-proof humanity against all future mutations.
-
Nipah Breakthrough: Japan To Begin First Human Vaccine Trial In April
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
-
Nipah Breakthrough: Japan To Begin First Human Vaccine Trial In April
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
-
Elon Musk's Startup Implants First Human Brain Chip. Here's How It Works
Elon Musk on Tuesday announced that his company Neuralink has implanted the first brain chip in a human patient. The initial results are "promising", the billionaire said, adding that the product is named Telepathy.
-
Playboy Model Aims To Be First With Elon Musk's Neuralink Chip: "I Could Climb Everest At 90"
Kayla Kayden, the 35-year-old adult film star, said she expects the chip to improve her brain power.
-
World's First Trial With Voluntary Covid Exposure Found Safe In Young Adults: Study
The world's first human challenge trial in which volunteers were deliberately exposed to COVID-19 to advance research into the disease was found to be safe in healthy young adults, one of the companies running the study said on Wednesday.
-
US COVID-19 Vaccine Hopeful Of Using Gates Foundation Cash To Prepare For Human Trial
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.
-
Covaxin Crosses Half-Way Mark In Phase-3 Trials, Says Bharat Biotech
India's first and only phase III trial of a COVID-19 vaccine has crossed 13,000 subjects - the half-way mark - and proceeding successfully across multiple sites in India, Bharat Biotech, the maker of the inoculant Covaxin, announced today. The trials in the first and second phases had led to promising results.
-
UAE To Host Second Human Trial Abroad Of Russia's COVID-19 Vaccine Sputnik V
Human trials of Russia's COVID-19 vaccine, named Sputnik V, will be held in the United Arab Emirates, the second country after Belarus to take part in the programme of which results are expected before the end of November, Moscow said on Monday.
-
Covishield Vaccine: Phase II Human Trial Of Oxford COVID-19 Vaccine Candidate Begins In Pune
The Phase II human clinical trial of the Oxford COVID-19 vaccine candidate, being manufactured by the Pune-based Serum Institute of India (SII), began at a medical college and hospital in the city today.
-
India Readies 5 Sites For Final Phase Of Human Trials Of Oxford COVID Vaccine
Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology (DBT) Renu Swarup said on Monday.
-
Man Receives First Dose Of Covaxin In Phase-I Of Human Trial At Delhi AIIMS
The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at Delhi AIIMS on Friday and the first dose of the injection was administered to a man who is in his 30s.
-
Oxford COVID-19 Vaccine Shows Promise In Early Testing: Study
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.
-
Human Clinical Trials For COVID Vaccine Initiated In India: Top Medical Body ICMR
Human clinical trials for a vaccine for COVID-19 has been initiated in the country with approximately 1,000 volunteers participating in the exercise for each of the two indigenously developed vaccine candidates, the ICMR said on Tuesday.
-
NewLink Says Ebola Vaccine Trial Could Start in Weeks
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
